Solentim will present at ASGCT 24th Annual Meeting

Solentim ASGCTSolentim, the trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, is pleased to announce that it will be presenting at American Society of Gene & Cell Therapy 24th Annual Meeting, 11-14th May.

Dr Ian Taylor, Chief Business Officer, Solentim, will present on Thursday 13th May, 11:30am-12:15pm EST. His talk, entitled “Robust workflow for single cell cloning of iPSCs for making cGMP Master Cell Banks” will highlight how high efficiency and documented single cell cloning of iPSCs will soon be a pre-requisite for allogeneic iPSC-derived cell therapies. Dr Taylor will:

  • Discuss the importance of the matrix, MatriClone
  • Illustrate the timeline improvements using the VIPS for single cell cloning iPSCs
  • Discuss cGMP requirements and considerations in choice of platform
  • Present new data for gene-edited iPSCs

ASGCT Virtual 2021 will bring together experts from around the globe who are working to advance knowledge, awareness, and education to expand the discovery and clinical application of gene and cell therapies for alleviation of human disease.

Solentim will also be exhibiting at the event and can be found at the virtual Exhibit Hall throughout the event. Get in touch with our team at the event regarding Solentim’s products and services or contact us here.